Goodhums Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 05-07-2024
- Paid Up Capital ₹ 1.10 Cr
as on 05-07-2024
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 139.07%
(FY 2021)
- Profit 1.06%
(FY 2021)
- Ebitda 10.77%
(FY 2021)
- Net Worth -54.58%
(FY 2021)
- Total Assets 67.21%
(FY 2021)
About Goodhums Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Virender Suri, Ranjeet Mishra, and Drishti Sharma serve as directors at the Company.
- CIN/LLPIN
U74999MH2018PTC311612
- Company No.
311612
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jul 2018
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Goodhums Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ranjeet Mishra  | Managing Director | 06-Jul-2018 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Virender Suri | Director | 01-Oct-2018 | Current |
| Drishti Sharma | Director | 06-Sep-2021 | Current |
Financial Performance of Goodhums Lifesciences.
Goodhums Lifesciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 139.07% increase. The company also saw a slight improvement in profitability, with a 1.06% increase in profit. The company's net worth observed a substantial decline by a decrease of 54.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Goodhums Lifesciences?
In 2021, Goodhums Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Goodhums Lifesciences?
Goodhums Lifesciences has a workforce of 26 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Goodhums Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Goodhums Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
